Brief: Dyadic Introduces Novel Method To Produce Synthetic Cannabinoids And Precursors Utilizing C1 Cell Line Production Platform And Patent Pending Process
20/01/2022 13:37
Jan 20 (Reuters) - Dyadic International Inc DYAI.O :
* DYADIC INTRODUCES NOVEL METHOD TO PRODUCE SYNTHETIC
CANNABINOIDS
AND PRECURSORS UTILIZING C1 CELL LINE PRODUCTION PLATFORM AND
PATENT PENDING PROCESS
Source text for Eikon: ID:nGNX7g2kQh
Further company coverage: DYAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dyadic International
See all newsDyadic International Inc reports results for the quarter ended June 30 - Earnings Summary
Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
Brief: Dyadic Announces Continued Listing On The Nasdaq Capital Market
Brief: Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development